Trial 3L-16-4


A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma

Type: Treatment
Phase: Phase I/II
Status: Not Open (Closed)
Treatments:
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Anthony El-Khoueiry, M.D.
Other Trial Staff:  Ramona Lujan, Coordinator, Yan Ning, D.M., Alicia Bogardus, Coordinator, Cristina De Leon, Coordinator, Bao-An Nguyen, D.M., Jiayi Jiang, D.M., Raluca Agafitei, Coordinator, Melissa Wallman, Coordinator, Noureddine Miloud, D.M., Yanli Wang, D.M., Pam McTague, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.